Generic Pharmaceutical Association (GPhA) CEO and President Chip Davis stated in a recent press release that generic drug savings were imperative to long-term solutions to rising health costs and explained that the focus should be on increasing pharmaceutical competition and expanding access to safe, effective and more affordable generic drugs. Read More »
Aldeyra Therapeutics Inc. has reported that its Phase 2a clinical trial of topical ocular NS2 has shown positive results. Read More »
GenSight Biologics S.A. announced this week that the first patient has enrolled in the company’s two parallel Phase 3 trials for GS010, a medicine designed to treat Leber’s Hereditary Optic Neuropathy (LHON). Read More »
Dan Durham, the EVP for Health Policy of the Biotechnology Innovation Organization (BIO), has released a statement in response to the White House’s announcement about its intent to fast-track the Precision Medicine Initiative. Read More »
CVS Health announced last week that its EVP and CFO, Dave Denton, will address investors at the Cowen and Co. 36th Annual Health Care Conference. Read More »
Curexa Pharmacy has received full accreditation status from the Utilization Review Accreditation Commission (URAC) due to its specialty pharmacy services. Read More »
The U.S. Food and Drug Administration (FDA) has approved Allegran’s prescription topical acne treatment for patients ages 12 and over, ACZONE Gel, 7.5%. Read More »
McKesson Corp. announced this week that it has agreed to terms to buy Vantage Oncology LLC and Biologics Inc. Read More »
Baxalta Inc., a worldwide leader in pharmaceuticals committed to developing therapies to combat orphan diseases, has announced the submission of supplemental Biologics License Applications (sBLAs) for the approval of ADYNOVATE by the U.S. Food and Drug Administration (FDA). Read More »
An estimated 3 percent of the world’s population struggles with the Hepatitis C virus (HCV), and rates have increased since the turn of the century. Read More »
The CVS Health Foundation announced this week that it has donated $550,000 to the Alzheimer’s Association. Read More »
Allegran announced this week that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for AVYCAZ and has granted the sNDA priority review status. Read More »
The National Association of Chain Drug Stores (NACDS) recently named Vonnie Hampel as its new director of federal government affairs. Read More »
Endo Pharmaceuticals Inc. announced this week that BELBUCA buccal film is now available. Read More »
Acorda Therapeutics Inc. announced last week that the waiting period has expired for its tender offer for Biotie Therapies, according to an amendment to the Hart-Scott-Rodino Antitrust Improvement Act of 1976 (HSR). Read More »
Sanofi made an announcement this week to confirm that its license and development agreement with kaleo will expire later this year. Read More »
PioneerRx and TCGRx have announced that the two pharmacies will be integrating PioneerRx’s system with TCGRx’s technology. Read More »
Pfizer Inc. announced last week that the United States Food and Drug Administration (FDA) has approved the expanded use of the drug IBRANCE (palbociclib). Read More »
PrescribeWellness and SinfoniaRx have announced that the two companies have signed an agreement that will allow for the optimization of medical treatments for millions of patients nationwide. Read More »
RelayHealth Financial announced last week a comprehensive agenda for the HIMSS16 Conference and Exhibition that will aid financial leaders in the health care industry to hurdle obstacles that disturb payments when the financial and clinical processes are not interconnected. Read More »
Alerts Sign-up
